Exciva

Heidelberg, Germany

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.

$59.4M raised

Jan 2026

Series B

Top Investors

Andera PartnersEQT Life SciencesModi VenturesFountain Healthcare PartnersCarma Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Exciva raised?

Exciva has raised $59.4M in total funding. The most recent round was Series B. The last funding was announced in January 2026.

Who are Exciva's investors?

Exciva's investors include Andera Partners, EQT Life Sciences, Modi Ventures, Fountain Healthcare Partners, Carma Fund.

Where is Exciva headquartered?

Exciva is headquartered in Heidelberg, Germany.

What does Exciva do?

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.

What stage is Exciva at?

Exciva is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 20, 2026.

MLA

"Exciva — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/exciva. Accessed June 3, 2026.

APA

VCBacked. (2026). Exciva — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/exciva

Wikipedia (cite web)

{{cite web |title=Exciva — Funding & Investors |url=https://www.vcbacked.co/company/exciva |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 20, 2026.